Results 211 to 220 of about 212,775 (379)

Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Discordant fibrinogen antigen to activity ratios are utilized by clinicians as evidence of dysfibrinogenemia. Abnormal ratio cutoffs implemented by clinical laboratories are typically determined by validation studies that include limited numbers of samples.
Abdulrahman Saadalla   +3 more
wiley   +1 more source

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova   +2 more
wiley   +1 more source

Von Willebrand factor and angiogenesis: basic and applied issues

open access: yesJournal of Thrombosis and Haemostasis, 2017
A. Randi, M. Laffan
semanticscholar   +1 more source

Nomogram for Deep Vein Thrombosis Prediction Post‐Endovascular Thrombectomy in Acute Ischemic Stroke: A Retrospective Multicenter Observational Study

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Background Deep vein thrombosis (DVT) is a frequent complication following endovascular thrombectomy (EVT) in patients with acute ischaemic stroke (AIS), potentially leading to fatal pulmonary embolism (PE). Identifying patients early at high risk for DVT is clinically important.
Li Han   +8 more
wiley   +1 more source

Topology and order of formation of interchain disulfide bonds in von Willebrand factor [PDF]

open access: bronze, 1987
DD Wagner   +4 more
openalex   +1 more source

Gaucher disease, state of the art and perspectives

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Intraindividual variability of von Willebrand factor and the need for repeated testing. [PDF]

open access: yesRes Pract Thromb Haemost
Kirkeby MH   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy